- Home
- CBNK vs CGEM Comparison
CBNK vs CGEM Comparison
Compare CBNK & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBNK
- CGEM
- Stock Information
- Founded
- CBNK 1974
- CGEM 2016
- Country
- CBNK United States
- CGEM United States
- Employees
- CBNK N/A
- CGEM N/A
- Industry
- CBNK Major Banks
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- CBNK Finance
- CGEM Health Care
- Exchange
- CBNK Nasdaq
- CGEM Nasdaq
- Market Cap
- CBNK 471.8M
- CGEM 490.3M
- IPO Year
- CBNK 2018
- CGEM 2021
- Fundamental
- Price
- CBNK $32.58
- CGEM $7.54
- Analyst Decision
- CBNK Hold
- CGEM Strong Buy
- Analyst Count
- CBNK 1
- CGEM 4
- Target Price
- CBNK $35.00
- CGEM $33.50
- AVG Volume (30 Days)
- CBNK 47.2K
- CGEM 457.5K
- Earning Date
- CBNK 04-28-2025
- CGEM 05-08-2025
- Dividend Yield
- CBNK 1.23%
- CGEM N/A
- EPS Growth
- CBNK 6.54
- CGEM N/A
- EPS
- CBNK 2.49
- CGEM N/A
- Revenue
- CBNK $188,910,000.00
- CGEM N/A
- Revenue This Year
- CBNK $43.37
- CGEM N/A
- Revenue Next Year
- CBNK $8.28
- CGEM N/A
- P/E Ratio
- CBNK $13.03
- CGEM N/A
- Revenue Growth
- CBNK 20.92
- CGEM N/A
- 52 Week Low
- CBNK $19.45
- CGEM $6.85
- 52 Week High
- CBNK $32.88
- CGEM $30.19
- Technical
- Relative Strength Index (RSI)
- CBNK 74.19
- CGEM 41.51
- Support Level
- CBNK $31.21
- CGEM $7.50
- Resistance Level
- CBNK $32.09
- CGEM $8.97
- Average True Range (ATR)
- CBNK 0.97
- CGEM 0.48
- MACD
- CBNK 0.41
- CGEM -0.04
- Stochastic Oscillator
- CBNK 97.85
- CGEM 2.72
About CBNK Capital Bancorp Inc.
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.